Stay updated on Parpvax: Niraparib + Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Parpvax: Niraparib + Immunotherapy Clinical Trial page.

Latest updates to the Parpvax: Niraparib + Immunotherapy Clinical Trial page
- ChecktodayChange DetectedA site-wide banner announces NIH website updates and says NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check7 days agoChange DetectedThe footer revision label was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer revision number changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, signaling an access restriction to the study record on ClinicalTrials.gov.SummaryDifference19%

- Check56 days agoChange DetectedThe page version was updated from v3.6.5 to v3.6.6, signaling a minor maintenance update to the page. This change reflects behind-the-scenes updates and does not modify the study details or eligibility information.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision label, v3.6.5, appears on the page replacing the previous v3.6.4, indicating a software version update.SummaryDifference0.1%

Stay in the know with updates to Parpvax: Niraparib + Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Parpvax: Niraparib + Immunotherapy Clinical Trial page.